1-6 of 6
Stefan R. Bornstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year

Free
Marko Barovic, Joke Johanna Hahn, Annett Heinrich, Trishla Adhikari, Peter Schwarz, Peter Mirtschink, Alexander Funk, Stefan Kabisch, Andreas F.H. Pfeiffer, Matthias Blüher, Jochen Seissler, Norbert Stefan, Robert Wagner, Andreas Fritsche, Reiner Jumpertz von Schwartzenberg, Sarantis Chlamydas, Hani Harb, Christos S. Mantzoros, Triantafyllos Chavakis, Annette Schürmann, Andreas L. Birkenfeld, Michael Roden, Michele Solimena, Stefan R. Bornstein, Nikolaos Perakakis
Journal: Diabetes Care
Diabetes Care 2025;48(3):405–415
https://doi.org/10.2337/dc24-1412
Published: 02 January 2025
View articletitled, Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year
Open the PDF for Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year in another window
Journal Articles

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

Free
Sabine Kahl, Sofiya Gancheva, Klaus Straßburger, Christian Herder, Jürgen Machann, Hisayuki Katsuyama, Stefan Kabisch, Elena Henkel, Stefan Kopf, Merit Lagerpusch, Konstantinos Kantartzis, Yuliya Kupriyanova, Daniel Markgraf, Theresa van Gemert, Birgit Knebel, Martin F. Wolkersdorfer, Oliver Kuss, Jong-Hee Hwang, Stefan R. Bornstein, Christian Kasperk, Norbert Stefan, Andreas Pfeiffer, Andreas L. Birkenfeld, Michael Roden
Journal: Diabetes Care
Diabetes Care 2020;43(2):298–305
https://doi.org/10.2337/dc19-0641
Published: 20 September 2019
View articletitled, Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Open the PDF for Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114

Free
Jens Jordan, Ali El-Armouche, Markolf Hanefeld, Stefan R. Bornstein, Andreas L. Birkenfeld
Journal: Diabetes Care
Diabetes Care 2016;39(12):e224–e225
https://doi.org/10.2337/dc16-1588
Published: 10 November 2016
View articletitled, Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114
Open the PDF for Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114 in another window
Journal Articles

Shifting the Disease Management Paradigm From Glucose: What are the cons?

Open Access
Markolf Hanefeld, MD, Stefan R. Bornstein, MD, Frank Pistrosch, MD
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S353–S356
https://doi.org/10.2337/dc09-S338
Published: 01 November 2009
View articletitled, Shifting the Disease Management Paradigm From Glucose: What are the cons?
Open the PDF for Shifting the Disease Management Paradigm From Glucose: What are the cons? in another window
Journal Articles

Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany: A population-based approach to health care research

Free
Ulrike Rothe, MD, Gabriele Müller, MPH, Peter E.H. Schwarz, MD, Martin Seifert, MSC, Hildebrand Kunath, PHD, MD, Rainer Koch, PHD, Sybille Bergmann, PHD, Ulrich Julius, PHD, MD, Stefan R. Bornstein, PHD, MD, Markolf Hanefeld, PHD, MD, Jan Schulze, PHD, MD
Journal: Diabetes Care
Diabetes Care 2008;31(5):863–868
https://doi.org/10.2337/dc07-0858
Published: 01 May 2008
View articletitled, Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany: A population-based approach to health care research
Open the PDF for Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany: A population-based approach to health care research in another window
Journal Articles

An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schulze et al.

Free
Peter E.H. Schwarz, MD, Jiang Li, MD, Heiko Wegner, MD, Stefan R. Bornstein, MD, PHD, Joana Lindström, PHD, Jaakko Tuomilehto, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(8):e87
https://doi.org/10.2337/dc07-0682
Published: 01 August 2007
View articletitled, An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schulze et al.
Open the PDF for An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schulze et al. in another window